NDC 65219-029

Thiotepa

Thiotepa

Thiotepa is a Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Thiotepa.

Product ID65219-029_a1ce70f8-1f22-4771-b51a-2e9b12876558
NDC65219-029
Product TypeHuman Prescription Drug
Proprietary NameThiotepa
Generic NameThiotepa
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRACAVITARY; INTRAVENOUS; INTRAVESICAL
Marketing Start Date2022-04-11
Marketing CategoryANDA /
Application NumberANDA214222
Labeler NameFresenius Kabi USA, LLC
Substance NameTHIOTEPA
Active Ingredient Strength100 mg/1
Pharm ClassesAlkylating Activity [MoA], Alkylating Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 65219-029-20

1 VIAL in 1 CARTON (65219-029-20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
Marketing Start Date2022-04-11
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Thiotepa" or generic name "Thiotepa"

NDCBrand NameGeneric Name
0143-9309ThiotepaThiotepa
0143-9565ThiotepaThiotepa
25021-246ThiotepaThiotepa
43598-171ThiotepaThiotepa
43598-650ThiotepaThiotepa
54879-014ThiotepaThiotepa
65219-029ThiotepaThiotepa
68083-446ThiotepaThiotepa
68083-503ThiotepaThiotepa
69539-123ThiotepaThiotepa
69539-124ThiotepaThiotepa
70860-220Thiotepathiotepa
72205-045ThiotepaThiotepa
72205-046ThiotepaThiotepa
53964-001TEPADINATHIOTEPA
53964-002TEPADINATHIOTEPA
70121-1630TEPADINATHIOTEPA
70121-1631TEPADINATHIOTEPA

Trademark Results [Thiotepa]

Mark Image

Registration | Serial
Company
Trademark
Application Date
THIOTEPA
THIOTEPA
73471323 not registered Dead/Abandoned
AMERICAN CYANAMID COMPANY
1984-03-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.